tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

Immuron plans Phase 2 trial for IMM-529 following FDA review
The FlyImmuron plans Phase 2 trial for IMM-529 following FDA review
15d ago
IMRN
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
PremiumPress Releases
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
15d ago
IMRN
Immuron’s IMM-529 Eyes Phase 2 Trial for CDI Treatment
PremiumCompany Announcements
Immuron’s IMM-529 Eyes Phase 2 Trial for CDI Treatment
15d ago
Immuron Limited Sees Revenue Surge Amid Rising R&D Costs
PremiumCompany Announcements
Immuron Limited Sees Revenue Surge Amid Rising R&D Costs
21d ago
Immuron Limited CEO to Present at Biotech Event
PremiumCompany Announcements
Immuron Limited CEO to Present at Biotech Event
1M ago
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
PremiumPress ReleasesImmuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
1M ago
IMRN
Immuron announces new DoD research award for NMRC
Premium
The Fly
Immuron announces new DoD research award for NMRC
1M ago
IMRN
Immuron Secures US Defense Grant to Advance Travelan
Premium
Company Announcements
Immuron Secures US Defense Grant to Advance Travelan
1M ago
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
PremiumPress Releases
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
1M ago
IMRN
Immuron Limited CEO to Host Informative Webinar
PremiumCompany Announcements
Immuron Limited CEO to Host Informative Webinar
1M ago
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
PremiumPress Releases
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
1M ago
IMRN
Immuron Limited Hosts Investor Webinar on Trial Update
PremiumCompany Announcements
Immuron Limited Hosts Investor Webinar on Trial Update
1M ago
BNYMC Group Reduces Stake in Immuron Limited
PremiumCompany AnnouncementsBNYMC Group Reduces Stake in Immuron Limited
2M ago
Immuron CEO to Present at TechKnow Roadshow
Premium
Company Announcements
Immuron CEO to Present at TechKnow Roadshow
2M ago
Immuron CEO to Highlight Biopharma Innovations
Premium
Company Announcements
Immuron CEO to Highlight Biopharma Innovations
2M ago
Immuron announces record Travelen sales globally
PremiumThe Fly
Immuron announces record Travelen sales globally
2M ago
IMRN
Immuron CEO to Unveil Key Biopharma Advances
PremiumCompany Announcements
Immuron CEO to Unveil Key Biopharma Advances
2M ago
Immuron CEO to Discuss Development and Sales at Sharewise
PremiumCompany Announcements
Immuron CEO to Discuss Development and Sales at Sharewise
3M ago
Immuron files $15M mixed securities shelf
PremiumThe Fly
Immuron files $15M mixed securities shelf
3M ago
IMRN
Immuron Expands Financial Horizons with U.S. SEC Filing
PremiumCompany AnnouncementsImmuron Expands Financial Horizons with U.S. SEC Filing
3M ago
Immuron requests pre-IND meeting for IMM-529 with FDA filing
Premium
Press Releases
Immuron requests pre-IND meeting for IMM-529 with FDA filing
3M ago
IMRN
Immuron requests pre-IND meeting for IMM-529
Premium
The Fly
Immuron requests pre-IND meeting for IMM-529
3M ago
IMRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >